XML 86 R69.htm IDEA: XBRL DOCUMENT
v2.4.1.9

OPERATING SEGMENT AND GEOGRAPHIC INFORMATION (Details) (USD $) In Thousands, unless otherwise specified | 3 Months Ended | 12 Months Ended
--- | --- | ---
Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 operating_segments | Dec. 31, 2013 | Dec. 31, 2012
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number of operating segments (in operating segments) |  |  |  |  |  |  |  |  | 2 us-gaap_NumberOfOperatingSegments |  |
Net Sales | $ 7,696 us-gaap_SalesRevenueNet | $ 6,372 us-gaap_SalesRevenueNet | $ 6,764 us-gaap_SalesRevenueNet | $ 6,251 us-gaap_SalesRevenueNet | $ 6,218 us-gaap_SalesRevenueNet | $ 6,646 us-gaap_SalesRevenueNet | $ 7,306 us-gaap_SalesRevenueNet | $ 7,374 us-gaap_SalesRevenueNet | $ 27,083 us-gaap_SalesRevenueNet | $ 27,544 us-gaap_SalesRevenueNet | $ 31,480 us-gaap_SalesRevenueNet
Gross Profit | 2,619 us-gaap_GrossProfit | 2,215 us-gaap_GrossProfit | 2,393 us-gaap_GrossProfit | 2,494 us-gaap_GrossProfit | 2,076 us-gaap_GrossProfit | 2,450 us-gaap_GrossProfit | 2,973 us-gaap_GrossProfit | 3,255 us-gaap_GrossProfit | 9,721 us-gaap_GrossProfit | 10,754 us-gaap_GrossProfit | 13,132 us-gaap_GrossProfit
Net Loss before Taxes |  |  |  |  |  |  |  |  | (13,418)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | (16,041)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | (8,181)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income Tax Expense |  |  |  |  |  |  |  |  | 524 us-gaap_IncomeTaxExpenseBenefit | (54)us-gaap_IncomeTaxExpenseBenefit | 146 us-gaap_IncomeTaxExpenseBenefit
NET LOSS | (5,793)us-gaap_NetIncomeLoss | (80)us-gaap_NetIncomeLoss | (3,893)us-gaap_NetIncomeLoss | (4,176)us-gaap_NetIncomeLoss | (3,982)us-gaap_NetIncomeLoss | (5,552)us-gaap_NetIncomeLoss | (2,867)us-gaap_NetIncomeLoss | (3,586)us-gaap_NetIncomeLoss | (13,942)us-gaap_NetIncomeLoss | (15,987)us-gaap_NetIncomeLoss | (8,327)us-gaap_NetIncomeLoss
Depreciation/Amortization |  |  |  |  |  |  |  |  | 2,248 us-gaap_DepreciationDepletionAndAmortization | 2,748 us-gaap_DepreciationDepletionAndAmortization | 2,278 us-gaap_DepreciationDepletionAndAmortization
Interest Expense |  |  |  |  |  |  |  |  | 665 tbio_InterestIncomeAndExpenseNet | 642 tbio_InterestIncomeAndExpenseNet | 888 tbio_InterestIncomeAndExpenseNet
Total Assets | 30,006 us-gaap_Assets |  |  |  | 30,278 us-gaap_Assets |  |  |  | 30,006 us-gaap_Assets | 30,278 us-gaap_Assets | 38,791 us-gaap_Assets
Goodwill | 6,918 us-gaap_Goodwill |  |  |  | 6,918 us-gaap_Goodwill |  |  |  | 6,918 us-gaap_Goodwill | 6,918 us-gaap_Goodwill | 6,918 us-gaap_Goodwill
Maximum |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Percent of revenue from countries not separately disclosed |  |  |  |  |  |  |  |  | 5.00%tbio_PercentOfRevenueFromCountriesNotSeparatelyDisclosed / us-gaap_RangeAxis = us-gaap_MaximumMember |  |
United states |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 21,052 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_US | 20,119 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_US | 22,727 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_US
United states | Minimum |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Long-lived asset percentage held in a specific location | 99.00%tbio_LongLivedAssetPercentageHeldInSpecificLocation / us-gaap_RangeAxis = us-gaap_MinimumMember / us-gaap_StatementGeographicalAxis = country_US |  |  |  |  |  |  |  | 99.00%tbio_LongLivedAssetPercentageHeldInSpecificLocation / us-gaap_RangeAxis = us-gaap_MinimumMember / us-gaap_StatementGeographicalAxis = country_US |  |
Italy |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 1,258 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_IT | 1,530 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_IT | 2,524 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_IT
United kingdom |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 881 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_GB | 748 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_GB | 1,703 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_GB
All Other Countries |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 3,892 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = tbio_AllOtherCountriesMember | 5,147 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = tbio_AllOtherCountriesMember | 4,526 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = tbio_AllOtherCountriesMember
Laboratory Services |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 16,520 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 15,391 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 19,329 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember
Gross Profit |  |  |  |  |  |  |  |  | 6,840 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 6,820 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 9,316 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember
Net Loss before Taxes |  |  |  |  |  |  |  |  | (14,691)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | (12,486)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | (6,874)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember
Income Tax Expense |  |  |  |  |  |  |  |  | 631 us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 0 us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 0 us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember
NET LOSS |  |  |  |  |  |  |  |  | (15,322)us-gaap_NetIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | (12,486)us-gaap_NetIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | (6,874)us-gaap_NetIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember
Depreciation/Amortization |  |  |  |  |  |  |  |  | 2,088 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 2,467 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 1,960 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember
Interest Expense |  |  |  |  |  |  |  |  | 406 tbio_InterestIncomeAndExpenseNet / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 398 tbio_InterestIncomeAndExpenseNet / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 851 tbio_InterestIncomeAndExpenseNet / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember
Total Assets | 23,116 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember |  |  |  | 21,711 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember |  |  |  | 23,116 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 21,711 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 29,196 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember
Goodwill | 6,918 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember |  |  |  | 6,918 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember |  |  |  | 6,918 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 6,918 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 6,918 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember
Genetic Assays and Platforms |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 10,563 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 12,153 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 12,151 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember
Gross Profit |  |  |  |  |  |  |  |  | 2,881 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 3,934 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 3,816 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember
Net Loss before Taxes |  |  |  |  |  |  |  |  | 1,273 us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | (3,555)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | (1,307)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember
Income Tax Expense |  |  |  |  |  |  |  |  | (107)us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | (54)us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 146 us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember
NET LOSS |  |  |  |  |  |  |  |  | 1,380 us-gaap_NetIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | (3,501)us-gaap_NetIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | (1,453)us-gaap_NetIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember
Depreciation/Amortization |  |  |  |  |  |  |  |  | 160 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 281 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 318 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember
Interest Expense |  |  |  |  |  |  |  |  | 259 tbio_InterestIncomeAndExpenseNet / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 244 tbio_InterestIncomeAndExpenseNet / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 37 tbio_InterestIncomeAndExpenseNet / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember
Total Assets | 6,890 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember |  |  |  | 8,567 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember |  |  |  | 6,890 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 8,567 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 9,595 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember
Goodwill | $ 0 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember |  |  |  | $ 0 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember |  |  |  | $ 0 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | $ 0 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | $ 0 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember

X
- Definition Interest income and (expense), net + References No definition available. + Details
Name: | tbio_InterestIncomeAndExpenseNet
Namespace Prefix: | tbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Long-lived asset percentage held in a specific location + References No definition available. + Details
Name: | tbio_LongLivedAssetPercentageHeldInSpecificLocation
Namespace Prefix: | tbio_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percent Of Revenue From Countries Not Separately Disclosed + References No definition available. + Details
Name: | tbio_PercentOfRevenueFromCountriesNotSeparatelyDisclosed
Namespace Prefix: | tbio_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 + Details
Name: | us-gaap_Assets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266 + Details
Name: | us-gaap_Goodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_GrossProfit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 10 -Article 5 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Income Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6515339 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 + Details
Name: | us-gaap_IncomeTaxExpenseBenefit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. + References No definition available. + Details
Name: | us-gaap_NumberOfOperatingSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_SalesRevenueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=tbio_ClinicalLaboratoriesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=tbio_GeneticAssaysandPlatformsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_GB
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_IT
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=tbio_AllOtherCountriesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |